MedicGo
Investigate Oral Zinc as a Prophylactic Treatment for Those at Risk for COVID-19.
Metadata
Journalamerican journal of ophthalmology4.013Date
2020 May 26
4 months ago
Type
Research Support, Non-U.S. Gov't
Editorial
Volume
2020-08 / 216 : A5-A6
Author
McPherson SW 1, Keunen JE 2, Bird AC 3, Chew EY 4, van Kuijk FJ 5
Affiliation
  • 2. Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • 3. Moorfields Eye Hospital, London, United Kingdom.
  • 4. Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • 5. Department of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, Minnesota, USA. Electronic address: [email protected]
Doi
PMIDMESH
Administration, Oral
Antiviral Agents
Betacoronavirus
Clinical Trials as Topic
Coronavirus Infections
Enzyme Inhibitors
Humans
Pandemics
Peptidyl-Dipeptidase A
Pneumonia, Viral
Zinc Compounds
Fav
Like
Download
Share
Export
Cite
4.0
Am J Ophthalmolamerican journal of ophthalmology
Metadata
LocationUnited States
FromELSEVIER SCIENCE INC

No Data

© 2017 - 2020 Medicgo
Powered by some medical students